Anti-lipopolysaccharide factor (32-51)[Y2A], L-2
General Information
DCTPep ID DCTPep03758
Peptide Name Anti-lipopolysaccharide factor (32-51)[Y2A], L-2
Sequence HARIKPTFRRLKWKYKGKFW
Sequence Length 20
UniProt ID P07086
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C129H196N38O23
Absent amino acids CDEMNQSV
Theoretical pI 11.76
Acidic residues 0
Basic residues 9
Polar residues 3
Molecular weight (Average) 2647.22
Molecular weight (Monoisotopic) 2645.53
Common amino acids K
Net charge 9
Instability index (II) 23.56
Aliphatic index 44.00
Grand average of hydropathicity (GRAVY) -1.315
Half Life
3.5 hours (mammalian reticulocytes, in vitro).
10 min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 12490
Abs 0.1% (=1 g/l) 4.718
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23401744
Title The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
Doi Not available
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 12315